CIK 0001835579
- Emerging growth company
ImageneBio, Inc.
Sign in to watch- Ticker
- IMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811697316
- Phone
- +1 857-343-8292
- Business address
- 12526 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
- Former names
- Ikena Oncology, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-28 | Marango Jotin Chief Financial Officer | Grant or award | +15,776 | 15,776 | ||
| 2025-07-28 | Marango Jotin Chief Financial Officer | Shares withheld for taxes | −4,630 | $17.16 | $79K | 11,146 |
| 2025-07-25 | Marango Jotin Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −181,000 | 0 | ||
| 2025-07-25 | Marango Jotin Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −105,000 | 0 | ||
| 2025-07-25 | Marango Jotin Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −397,199 | 0 | ||
| 2024-02-01 | Marango Jotin CFO & Head of Corp. Dev. | Grant or award · Stock Option (Right to Buy) | +181,000 | 181,000 | ||
| 2023-01-03 | Marango Jotin CFO & Head of Corp. Dev. | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2022-04-25 | Marango Jotin CFO & Head of Corp. Dev. | Grant or award · Stock Option (Right to Buy) | +397,199 | 397,199 |
Page 1 of 1 · 8 trades